Analysis of the efficacy of poly ADP?ribose polymerases inhibitor combined with chemotherapeutics in the treatment of triple negative breast cancer / 中国综合临床
Clinical Medicine of China
; (12): 422-426, 2019.
Article
de Zh
| WPRIM
| ID: wpr-754328
Bibliothèque responsable:
WPRO
ABSTRACT
Objective To investigate the effects of poly adenosine diphosphate ribose polymerase (PARP) inhibitor AG014699 on the proliferation of triple negative breast cancer (TNBC) cell line MDA?MB?231.Methods Cell proliferation and cytotoxicity test kit ( CCK?8) was used to detect the proliferation of MDA?MB?231 cells in different concentrations of AG014699 (0.1,1.0,10.0,20.0 and 40.0 mmol/L), DTX (10-9,10-8,10-7,10-6 and 10-5 mol/L) and CBP (10-6,10-5,10-4 and 10-3 mol/L).Flow cytometry was used to detect cell apoptosis and cell cycle distribution.Results The effects of AG01469 at different concentrations (0.1,1.0,10.0,20.0 and 40.0 μmol/L) on proliferation activity of MDA?MB?231 cells were (94.83 ± 3.93)%, ( 79.42 ± 5.52)%, ( 63.75 ± 4.34)%, ( 38.97 ± 8.42)%, ( 29.70 ± 3.35 )%, with statistically significant differences (F=75.54,P<0.01,different concentrations pairwise comparison: all P <0.05). The efficacy of AG014699 in combination with DTX at different concentrations (( 69.77 ±17.94)%,(58.34± 2.59)%,( 52.81 ± 2.01)%, ( 41.23 ± 3.38)%, ( 24.82 ± 0.73)%) was compared with that of single DTX (( 81.24 ± 11.91)%, ( 85.74 ± 3.10)%, ( 72.74 ± 4.66)%, ( 55.18 ± 3.19)%, (45.95±3.82)%).The differences were statistically significant (t values were -0.923,-11.748,-6.802,-5.199,-9.410,respectively,with P>0.05 at 10-9 concentration and P<0.01 at all other concentrations ). The efficacy of AG014699 combined with CBP ((78.33± 2.89)%,( 60.44± 1.95)%,( 50.55± 3.07)%, (12.07± 1.63)%) and single CBP (( 90.00 ± 6.18)%, ( 87.87 ± 2.30)%,( 76.82 ± 3.37)%,( 40.71 ±1.68)%) was compared,and the cell activity was significantly reduced,indicating statistically significant differences ( t values were -1.935,-15.756,-9.981,-21.192, respectively, and P>0.05 at 10-6 concentration,P<0.05 at all the other concentrations ).The q value was>1.15 when AG014699 was combined with 10-3 mmol/L CBP, which showed synergistic effect.When combined with other effective concentrations of DTX or CBP,the q value was between 0.85 and 1.15,showing additive effect.Conclusion PARP inhibitor AG014699 assisted DTX or CBP can inhibit the proliferation of TNBC cell line MDA?MB?231.By means of simple addition or systematic effect,it can inhibit the triple negative breast cancer.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Clinical Medicine of China
Année:
2019
Type:
Article